Date: January 30, 2019
Time: 8:00AM - 9:00AM
In 2018, health care fraud enforcement remained a top government priority and will continue to be at the forefront of governmental activity in 2019. In this annual webinar and the accompanying viewpoint series, Mintz’s Health Care Enforcement Defense Team will review the key 2018 government health care enforcement actions and case developments and the likely impact of these trends on events in 2019.
Topics will include:
• Important issues related to defending investigations and litigation arising from qui tam cases
• The increase in civil and criminal enforcement actions initiated against individuals
• Opioid-related enforcement
• Key False Claims Act developments, including the application of the Escobar materiality standard and the viability of cases premised on medical necessity
• The impact of the Granston memo, increased DOJ dismissals of declined False Claims Act cases, and other DOJ policy developments
Hope regularly defends health care companies in governmental investigations and ensuing cases, conducts internal investigations, and advises providers and manufacturers regarding enforcement issues.
Karen advises industry clients on regulatory, transactional, operational, and enforcement matters. She has deep experience handling FCA investigations and qui tam litigation for laboratories and diagnostics companies.
Eóin P. Beirne is a white collar defense lawyer at Mintz. He guides clients from a wide range of industries through investigations and enforcement proceedings and represents them in state and federal courts. Eóin handles matters related to health care fraud, public corruption, and insider trading.
As a former official in the Civil Fraud Section of the U.S. Department of Justice, Larry has deep experience handling FCA investigations and qui tam litigation for industry leading health care clients across the country.